Law Firms

A unit of spirits maker Pernod Ricard has lost its opposition to rival Sazerac's bid to register 'Stagg' as a trade mark for a whiskey brand, with an IP Australia delegate finding the mark was not deceptively similar to Pernod Ricard's 'Royal Stag' mark. 

A judge has allowed Adani unit Bravus to bring a $22 million counterclaim against Isaac Regional Council in Queensland, alleging it breached an agreement to upgrade a 96-kilometre road to access the Carmichael mine.

An appeals court has tossed a challenge to a judgment against Polyaire, the lessee of an industrial premises in Sydney, after a judge found the air conditioning wholesaler was responsible for a fire that ignited after pellets were left exposed to the rain and sun.

The developer behind a Sydney housing project at the centre of a class action has warned that the plaintiffs’ proposed amendments to the case could jeopardise the start date of trial in the case.

Zip Co will have to rebrand after losing a challenge to non-bank lender Firstmac’s ‘Zip’ trade mark, with the High Court finding the honest concurrent use is to be judged by the standards of “ordinary, decent people”, not a subjective “Robin Hood” test. 

A judge has tossed an environmental group's bid for judicial review of a minister's approval of plans to build water regulating structures at the Nyah Floodplain in Victoria, saying the approval was contingent on plans to offset effects on the Regent parrot.

Mayne Pharma cannot access invoices from Cosette’s solicitors at Corrs Chambers Westgarth, with a judge saying he was not hopeful that they would help to resolve a costs fight related to litigation over their collapsed $672 million merger.

AkzoNobel has lost its bid to add new expert evidence after the conclusion of trial in a dispute with Inpex over allegedly defective anti-corrosive coating used on the $45 billion Ichthys natural gas project.

Shell’s Australian arm has succeeded in challenging a finding by the ATO that it needed to pay an additional $99 million in capital gains tax after it disposed of its 34.27 per cent holding in Woodside Petroleum.

Trial in AstraZeneca's patent infringement case over Pharmacor's plans to launch a cheaper version of diabetes drug Forxiga has been delayed to October, after the generic drug maker got the all-clear to revise its cross-claim.